Results 11 to 20 of about 7,578 (214)

CVID Associated with Systemic Amyloidosis [PDF]

open access: yesCase Reports in Immunology, 2015
Common variable immunodeficiency (CVID) is a frequent primary immune deficiency (PID), which consists of a heterogeneous group of disorders and can present with recurrent infections, chronic diarrhea, autoimmunity, chronic pulmonary and gastrointestinal diseases, and malignancy. Secondary amyloidosis is an uncommon complication of CVID.
Esenboga, Saliha   +5 more
core   +7 more sources

OBIČNA VARIJABILNA IMUNODEFICIJENCIJA (CVID) [PDF]

open access: yesSCRIPTA PEDIATRICA, 2018
Obična varijabilna imunodeficijencija (CVID) je primarni poremećaj imuniteta koga karakteriše smanjena sposobnostproizvodnje imunoglobulina. CVID ima incidenciju od 1:10.000 do 1: 200.000 (odnos muškog i ženskog polaje 1:1) i obično se javlja i dijagnostikuje iza desete godine života.
Želimir Erić   +1 more
core   +5 more sources

A Computational Pipeline for the Diagnosis of CVID Patients [PDF]

open access: yesFrontiers in Immunology, 2019
Common variable immunodeficiency (CVID) is one of the most frequently diagnosed primary antibody deficiencies (PADs), a group of disorders characterized by a decrease in one or more immunoglobulin (sub)classes and/or impaired antibody responses caused by inborn defects in B cells in the absence of other major immune defects.
Annelies Emmaneel   +13 more
openaire   +6 more sources

Failure of B Cell Tolerance in CVID [PDF]

open access: yesFrontiers in Immunology, 2019
Common variable immunodeficiency (CVID) comprises a group of related disorders defined by defects in B cell function and antibody production. Concurrent autoimmune features are common, but the underlying pathogenic mechanisms of autoimmunity in CVID are ...
Christopher T. Richardson   +10 more
doaj   +3 more sources

Osteoporosis: An ignored complication of CVID [PDF]

open access: yesPediatric Allergy and Immunology, 2011
To cite this article: Baris S, Ozen A, Ercan H, Karakoc‐Aydiner E, Cagan H, Ozdemir C, Barlan M, Bahceciler NN, Barlan IB. Osteoporosis: An ignored complication of CVID. Pediatric Allergy Immunology 2011; 22: 676–683.AbstractBackground:  Multiple factors in common variable immunodeficiency (CVID) might interfere with optimal growth and maturation and ...
Safa, Baris   +8 more
openaire   +4 more sources

COVID‐19 infection in CVID patients: What we know so far [PDF]

open access: yesImmunity, Inflammation and Disease, 2021
Introduction In patients with common variable immunodeficiency (CVID), immunological response is compromised. Knowledge about COVID‐19 in CVID patients is sparse. We, here, synthesize current research addressing the level of threat COVID‐19 poses to CVID
Niels Weifenbach   +2 more
doaj   +2 more sources

Interstitial lung diseases (ILD) in common variable immunodeficiency (CVID) patients: a study from Iran [PDF]

open access: yesBMC Immunology
Introduction Interstitial lung disease (ILD) is a prevalent complication in patients with common variable immunodeficiency (CVID) and is often related to other characteristics such as bronchiectasis and autoimmunity.
Ghamartaj Khanbabaee   +8 more
doaj   +2 more sources

Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency

open access: yesFrontiers in Immunology, 2022
Common variable immunodeficiency (CVID) represents the largest group of primary immunodeficiencies that may manifest with infections, inflammation, autoimmunity, and cancer, mainly B-cell non-Hodgkin’s lymphoma (NHL).
Kissy Guevara-Hoyer   +21 more
doaj   +1 more source

Clinical and laboratory parameter analysis in patients with common Variable Immunodeficiency [PDF]

open access: yesMedicinski Podmladak, 2022
Introduction: Common Variable Immunodeficiency (CVID) is the most prevalent primary immunodeficiency in adult population. The diagnosis is based on low concentration of at least 2 immunoglobulin classes, mostly IgG, with low IgA and/or IgM.
Krtinić Danka, Stojanović Maja
doaj  

Importance of cellular immunity link for efficiency of replacement therapy in common variable immune deficiency

open access: yesМедицинская иммунология, 2020
Lifetime use of IgG replacement therapy  is the standard of CVID treatment. However, full control over stabilization of chronic infection loci is not always achieved, even if this therapy  is continuously applied.
L. P. Sizyakina   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy